Pro-Dex Inc

Pro-Dex Inc(PDEX)の株式分析

$63.440

+3.369 (+5.31%)終値時点

Loading chart…
高値
63.660
始値
61.010
出来高加重平均価格
62.70
出来高
38.94K
時価総額
64.62M
安値
61.010
売買代金
2.44M
EV/EBITDA(TTM)
12.25

Pro-Dex, Inc. specializes in the design, development, and manufacture of autoclavable, battery-powered and electric, multi-function surgical drivers and shavers used primarily in the orthopedic, thoracic, and maxocranial facial markets. The Company has patented adoptive torque-limiting software and sealing solutions, which appeal to its customers, primarily medical device distributors. It also manufactures and sells rotary air motors to a range of industries. The Company’s medical device products utilize designs developed by it primarily under development and supply agreements and are machined in its Irvine, California facility, and assembled in its Tustin, California facility, as are its rotary air motors. Its medical device products are sold primarily to original equipment manufacturers and its air motors are sold primarily to a range of distributors and end users. It manufactures machined sub-assemblies and also produces parts and assemblies for aerospace and defense systems.

www.pro-dex.com

AI分析 of Pro-Dex Inc (PDEX)

中立

Currently, Pro-Dex Inc (PDEX) is trading at $57.65, which is significantly below its 52-week high of $77.00, indicating potential for recovery. However, the RSI is at 29.815, suggesting it is in oversold territory, which could lead to a rebound. The forward P/E ratio is 19.12, indicating that the stock may be overvalued based on future earnings expectations. The company reported a net income of $13.66 million for FY 2026, a 52% increase from the previous year, which is a positive sign for long-term investors. However, the stock has seen a 4.96% decline over the past five days, which reflects short-term volatility. Given these factors, it may be prudent to hold rather than buy at this moment, as the stock could stabilize before making a more informed investment decision.

アナリスト評価(1)

買い
1 買い
0 中立
0 売り
現在: 63.44
安値
—
平均
—
高値
—

Ascendiant Capital

2024-11-11

目標株価

$52

強い買い

Ascendiant Capital

2024-09-09

目標株価

$30

強い買い

バリュエーション指標

Pro-Dex Inc(PDEX)の現在の予想PERは18.66で、5年平均は17.42です。

予想PER

適正
5年平均 P/E
17.42
現在のP/E
18.66
割高
23.31
割安
11.53

予想EV/EBITDA

適正
5年平均 EV/EBITDA
10.48
現在のEV/EBITDA
12.25
割高
13.50
割安
7.45

予想PSR

割高
5年平均 P/S
1.70
現在のP/S
2.22
割高
2.19
割安
1.20

Alphio AI による PDEX の価格シナリオ

シナリオ価格は本年の最終月次予想レンジです。確率はモデルの固定ウェイト(25 / 50 / 25)であり、保証ではありません。

強

強気

強気 · 25%PDEX

$55.23

シナリオ価格

基

基本

基本 · 50%PDEX

$51.89

シナリオ価格

弱

弱気

弱気 · 25%PDEX

$51.20

シナリオ価格

PDEX のよくある質問 — Alphio AI が回答

Pro-Dex, Inc. specializes in the design, development, and manufacture of autoclavable, battery-powered and electric, multi-function surgical drivers and shavers used primarily in the orthopedic, thoracic, and maxocranial facial markets. The Company has patented adoptive torque-limiting software and sealing solutions, which appeal to its customers, primarily medical device distributors. It also manufactures and sells rotary air motors to a range of industries. The Company’s medical device products utilize designs developed by it primarily under development and supply agreements and are machined in its Irvine, California facility, and assembled in its Tustin, California facility, as are its rotary air motors. Its medical device products are sold primarily to original equipment manufacturers and its air motors are sold primarily to a range of distributors and end users. It manufactures machined sub-assemblies and also produces parts and assemblies for aerospace and defense systems. It operates in the Healthcare sector (SURGICAL & MEDICAL INSTRUMENTS & APPARATUS industry).

Currently, Pro-Dex Inc (PDEX) is trading at $57.65, which is significantly below its 52-week high of $77.00, indicating potential for recovery. However, the RSI is at 29.815, suggesting it is in oversold territory, which could lead to a rebound. The forward P/E ratio is 19.12, indicating that the stock may be overvalued based on future earnings expectations. The company reported a net income of $13.66 million for FY 2026, a 52% increase from the previous year, which is a positive sign for long-term investors. However, the stock has seen a 4.96% decline over the past five days, which reflects short-term volatility. Given these factors, it may be prudent to hold rather than buy at this moment, as the stock could stabilize before making a more informed investment decision.

1 analysts cover PDEX: 1 rate it Buy, 0 Hold and 0 Sell.

コミュニティ

もっと見る ↗

投稿はまだありません

登録またはログインして議論に参加

関連記事

本ページは調査目的であり、投資助言ではありません。モデルは誤ることがあります。過去の実績は将来の成果を保証しません。

取引を始める